Bristol-Myers Squibb

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. 

CEO
Christopher S. Boerner
CEOChristopher S. Boerner
Employees
32,500
Employees32,500
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1933
Founded1933
Employees
32,500
Employees32,500

BMY Key Statistics

Market cap
117.63B
Market cap117.63B
Price-Earnings ratio
16.44
Price-Earnings ratio16.44
Dividend yield
4.27%
Dividend yield4.27%
Average volume
16.38M
Average volume16.38M
High today
$58.88
High today$58.88
Low today
$57.27
Low today$57.27
Open price
$58.74
Open price$58.74
Volume
11.35M
Volume11.35M
52 Week high
$62.89
52 Week high$62.89
52 Week low
$42.52
52 Week low$42.52

Stock Snapshot

As of today, Bristol-Myers Squibb(BMY) shares are valued at $57.35. The company's market cap stands at 117.63B, with a P/E ratio of 16.44 and a dividend yield of 4.27%.

On 2026-06-30, Bristol-Myers Squibb(BMY) stock traded between a low of $57.27 and a high of $58.88. Shares are currently priced at $57.35, which is +0.1% above the low and -2.6% below the high.

Bristol-Myers Squibb(BMY) shares are trading with a volume of 11.35M, against a daily average of 16.38M.

In the last year, Bristol-Myers Squibb(BMY) shares hit a 52-week high of $62.89 and a 52-week low of $42.52.

In the last year, Bristol-Myers Squibb(BMY) shares hit a 52-week high of $62.89 and a 52-week low of $42.52.

BMY News

Nasdaq 7h
Dell Technologies Now #100 Largest Company, Surpassing Bristol Myers Squibb

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Dell Technologies Inc (Symbol: DELL) has taken over the...

Dell Technologies Now #100 Largest Company, Surpassing Bristol Myers Squibb
Nasdaq 13h
Ex-Div Reminder for Bristol Myers Squibb

Looking at the universe of stocks we cover at Dividend Channel , on 7/2/26, Bristol Myers Squibb Co. (Symbol: BMY) will trade ex-dividend, for its quarterly div...

Ex-Div Reminder for Bristol Myers Squibb
Simply Wall St 2d
There's A Lot To Like About Bristol-Myers Squibb's Upcoming US$0.63 Dividend

Bristol-Myers Squibb Company ( ) stock is about to trade ex-dividend in two days. The ex-dividend date is usually set to be one business day before the record d...

There's A Lot To Like About Bristol-Myers Squibb's Upcoming US$0.63 Dividend

Analyst ratings

60%

of 30 ratings
Buy
36.7%
Hold
60%
Sell
3.3%

More BMY News

Simply Wall St 6d
What Bristol-Myers Squibb's Phase 3 Izalontamab Results Mean For Shareholders

Earlier in June, Bristol Myers Squibb and SystImmune reported interim Phase 3 results showing izalontamab brengitecan improved overall and progression-free surv...

What Bristol-Myers Squibb's Phase 3 Izalontamab Results Mean For Shareholders

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.